Every terminated drug program leaves behind a fingerprint of why it failed. AI can now read those fingerprints — and turn them into the blueprint for the next success Pharmaceutical R&D generates failure at an extraordinary rate — and buries it. >90% of discovery programs never reach an IND. ~70% of Phase II trials fail […]